共 50 条
- [41] Association of plasma EGFR T790M ctDNA status with clinical outcome in advanced NSCLC patients with acquired EGFR-TKI resistance.JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)Zheng, DiYe, XinZhang, MeizhuoSun, YunWang, JiyingNi, JianZhang, HaipingZhang, LingLuo, JieZhang, JieTang, LiangSu, BoChen, GangZhu, GuanshanGu, YiXu, Jianfang
- [42] Deciphering mechanisms of acquired T790M mutation after EGFR inhibitors for NSCLC by computational simulationsScientific Reports, 7Bin ZouVictor H. F. LeeLijiang ChenLichun MaDebby D. WangHong Yan
- [43] Deciphering mechanisms of acquired T790M mutation after EGFR inhibitors for NSCLC by computational simulationsSCIENTIFIC REPORTS, 2017, 7Zou, BinLee, Victor H. F.Chen, LijiangMa, LichunWang, Debby D.Yan, Hong
- [44] Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer PatientsSCIENTIFIC REPORTS, 2016, 6Matsuo, NorikazuAzuma, KoichiSakai, KazukoHattori, SatoshiKawahara, AkihikoIshii, HidenobuTokito, TakaakiKinoshita, TakashiYamada, KazuhikoNishio, KazutoHoshino, Tomoaki
- [45] Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer PatientsScientific Reports, 6Norikazu MatsuoKoichi AzumaKazuko SakaiSatoshi HattoriAkihiko KawaharaHidenobu IshiiTakaaki TokitoTakashi KinoshitaKazuhiko YamadaKazuto NishioTomoaki Hoshino
- [46] Association of EGFR Exon 19 Deletion and EGFR-TKI treatment duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer PatientsJOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1201 - S1202Matsuo, NorikazuAzuma, KoichiSakai, KazukoKawahara, AkihikoIshii, HidenobuTokito, TakaakiKinoshita, TakashiYamada, KazuhikoNishio, KazutoHoshino, Tomoaki
- [47] T790M mutation is associated with better efficacy of treatment beyond progression with EGFR-TKI in advanced NSCLC patientsLUNG CANCER, 2014, 84 (03) : 295 - 300Li, WeiRen, ShengxiangLi, JiayuLi, AiwuFan, LihongLi, XuefeiZhao, CaoHe, YayiGao, GuanghuiChen, XiaoxiaLi, ShuaiShi, JingyunZhou, CaicunFei, KeSchmid-Bindert, Gerald
- [48] Low Positivity Rate in T790M Detection with ctDNA in NSCLC and Post EGFR-TKI Progression - Timing or Sensitivity?JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S714 - S714Ferreira, C. G.Zalis, M.Zukin, M.Mathias, C.Haddad, C.Mascarenhas, E.Araujo, L. H.Montella, T.Custodio, M.Silva, B.Bustamante, C.Montenegro, G.Muras, A.Reis, M.
- [49] Role of T790M Mutation in EGFR-TKI Rechallenge for Patients with EGFR-Mutant Advanced Non-Small Cell Lung CancerJOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S271 - S271Zhang, Qiu-YiKe, E-EDeng, WeiNiu, Fei-YuZhao, NingSu, JianChen, Zhi-HongYang, Jin-JiXu, Chong-RuiYan, Hong-HongWu, Yi-LongZhou, Qing
- [50] Incidence, characteristics, and survival of patients with EGFR-mutant lung cancers with EGFR T790M at diagnosis identified in the lung cancer mutation consortium (LCMC)JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)Kris, Mark G.Oxnard, Geoffrey R.Johnson, Bruce E.Berry, Lynne D.Chen, HeidiKwiatkowski, David J.Iafrate, Anthony JohnWistuba, Ignacio IvanFranklin, Wilbur A.Aisner, DaraSequist, Lecia V.Khuri, Fadlo RajaGaron, Edward B.Pao, WilliamRudin, Charles M.Schiller, Joan H.Haura, Eric B.Minna, John D.Bunn, Paul A.